Aztreonam, 1 g intramuscularly, was compared with spectinomycin, 2 g intramuscularly, for uncomplicated gonorrhea. There were no failures with either drug. For aztreonam, there were 26 urethral, 3 rectal, and 3 endocervical sites that were infected. Aztreonam in a single dose of 1 g intramuscularly is satisfactory therapy for uncomplicated urethral gonorrhea in men and may be effective for rectal and endocervical infection as well.
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Aztreonam is the first of a new class of beta-lactam antimicrobial agents, the monobactams. These agents have a monocyclic beta-lactam ring without the secondary ring found in penicillins and cephalosporins (1) . Like these other beta-lactams, aztreonam kills susceptible organisms by interfering with synthesis of bacterial cell wall. Aztreonam has in vitro activity against gram-negative organisms such as the Enterobacteriaceae, Hemophilus influenzae, Pseudomonas spp., and Neisseria gonorrhoeae equivalent to that reported for the new third-generation cephalosporins (2) (3) (4) 8) . All strains of N. gonorrhoeae, including those producing betalactamase, are highly susceptible to aztreonam (5) . In humans the drug produces good serum levels with a half-life of about 1.5 (7) . Because this drug is resistant to gonococcal beta-lactamase it would almost certainly be effective for penicillinase-producing Neisseria spp., and clinical studies to date have confirmed this (5) . Although this agent is unlikely to replace existing agents for parenteral single-dose therapy of uncomplicated gonorrhea, it may be used in conjunction with other drugs for empiric treatment of conditions possibly due to the gonococcus (e.g., salpingitis, arthritis) where reliable antimicrobial activity toward the gonococcus is important. 
